ALK History

ALK has been working in the allergy field since 1923, concentrating our skills and resources on the development, production and distribution of products for patients suffering with allergies. Our driving force is a wish to understand the basic mechanisms of allergy.

ALK is a global pharmaceutical company focusing on allergy treatment, prevention and diagnosis. ALK is a world leader in allergy vaccination (immunotherapy) – the only treatment which treats the underlying cause of allergy.

ALK is devoted to improving the quality of life for people with allergies.

ALK has more than 2,000 employees with subsidiaries in several European countries, in the USA and in China. ALK is an independent  company, listed on the Danish stock exchange with global headquarters in Hørsholm, Denmark.

Last updated: 2017.02.28